These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36907877)

  • 1. An EMT-based gene signature enhances the clinical understanding and prognostic prediction of patients with ovarian cancers.
    Li QJ; Wu ZL; Wang J; Jiang J; Lin B
    J Ovarian Res; 2023 Mar; 16(1):51. PubMed ID: 36907877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
    Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
    Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
    Fei H; Han X; Wang Y; Li S
    J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer.
    Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a transcription factors-based prognostic signature for ovarian cancer.
    Cheng Q; Li L; Yu M
    J Ovarian Res; 2022 Feb; 15(1):29. PubMed ID: 35227285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
    Li Q; Xiao X; Feng J; Yan R; Xi J
    Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
    Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
    J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer.
    Zhang B; Zhao R; Wang Q; Zhang YJ; Yang L; Yuan ZJ; Yang J; Wang QJ; Yao L
    Adv Ther; 2023 Oct; 40(10):4339-4357. PubMed ID: 37462865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
    Pi Y; Sun F; Zhang Z; Liu X; Lou G
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.